The global pharmaceutical equipment market is recovering

The global pharmaceutical equipment market has witnessed a recovery, with three major listed companies demonstrating strong growth momentum. The global pharmaceutical equipment market experienced a significant recovery in the third quarter of 2025, driving substantial growth in the performance of several listed companies.

Due to the recovery of the demand side, in the third quarter of 2025, the pharmaceutical equipment industry witnessed a significant turning point. The performance of related listed companies generally showed a turning point. This industry's turning point was also attributed to the recovery of the global pharmaceutical industry, and capacity expansion became a new cycle, which provided a huge impetus for the pharmaceutical equipment industry.

【Strong Performance Growth】 In the third quarter of 2025, Chutian Technology demonstrated a strong growth momentum. The company achieved a revenue of 1.479 billion yuan and a net profit of 96.77 million yuan, with non-GAAP net profit reaching 77.30 million yuan. Compared with the same period last year, these figures showed a year-on-year growth of 10.17%, 192.50%, and 170.02% respectively. Although the net profit was negative in the first half of the year, Chutian Technology achieved a significant turnaround from loss to profit in the first three quarters of 2025, with both total revenue and net profit showing substantial growth.

Meanwhile, Dongfulong also made significant progress in the third quarter. The company achieved a revenue of 1.275 billion yuan, a net profit of 85.66 million yuan, and a non-GAAP net profit of 79.97 million yuan, with year-on-year growth rates of 6.39%, 120.91%, and 142.91% respectively. Compared with the performance in the first half of the year, Dongfulong's performance in the third quarter has significantly improved. This is the first time since 2022 that the company has achieved a substantial increase in its single-quarter performance.

In addition to the growth in revenue and profits, the contract liabilities have also been continuously increasing. From 2023 to the end of September 2025, Dongfulong's contract liability balance rose from 3.112 billion yuan to 3.657 billion yuan. Meanwhile, Chu Tian Technology's contract liability balance at the end of the third quarter reached 2.959 billion yuan, setting a new record high.